Ethical and safety issues of stem cell-based therapy part 29

Stem cell 5

 

 

 

Mesenchymal stem cells as a promising tool in the therapy of cardiac diseases

Several studies have examined therapeutic potential of autologous and allogeneic mesenchymal stem cells in the treatment of acute myocardial infarction. In a phase I clinical study, 53 patients were randomized to receive either allogeneic mesenchymal stem cells or placebo, 7 to 10 days after myocardial infarction. An improvement of overall clinical status was noticed 6 months after intravenous infusion of mesenchymal stem cells. Chen and colleagues administered autologous mesenchymal stem cells intra-coronary in patients with subacute myocardial infarction and observed decreased perfusion defect, improved left ventricular ejection  fraction, and left ventricular remodeling 3 months after therapy.

 

Advertisements

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s